Berg K - Search Results

1

Assessing autophagy in the context of photodynamic therapy.

Reiners JJ Jr, Agostinis P, Berg K, Oleinick NL, Kessel D. Reiners JJ Jr, et al. Among authors: berg k. Autophagy. 2010 Jan;6(1):7-18. doi: 10.4161/auto.6.1.10220. Epub 2010 Jan 1. Autophagy. 2010. PMID: 19855190 Free PMC article. Review.

2

Photodynamic therapy of cancer: an update.

Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J. Agostinis P, et al. Among authors: berg k. CA Cancer J Clin. 2011 Jul-Aug;61(4):250-81. doi: 10.3322/caac.20114. Epub 2011 May 26. CA Cancer J Clin. 2011. PMID: 21617154 Free PMC article. Review.

3

Development of resistance to photodynamic therapy (PDT) in human breast cancer cells is photosensitizer-dependent: Possible mechanisms and approaches for overcoming PDT-resistance.

Olsen CE, Weyergang A, Edwards VT, Berg K, Brech A, Weisheit S, Høgset A, Selbo PK. Olsen CE, et al. Among authors: berg k. Biochem Pharmacol. 2017 Nov 15;144:63-77. doi: 10.1016/j.bcp.2017.08.002. Epub 2017 Aug 5. Biochem Pharmacol. 2017. PMID: 28784290

4

Photodynamic therapy enhances the efficacy of gene-directed enzyme prodrug therapy.

Christie C, Pomeroy A, Nair R, Berg K, Hirschberg H. Christie C, et al. Among authors: berg k. Photodiagnosis Photodyn Ther. 2017 Jun;18:140-148. doi: 10.1016/j.pdpdt.2017.02.016. Epub 2017 Feb 28. Photodiagnosis Photodyn Ther. 2017. PMID: 28257943 Free PMC article.

5

Photodynamic therapy with an endocytically located photosensitizer cause a rapid activation of the mitogen-activated protein kinases extracellular signal-regulated kinase, p38, and c-Jun NH2 terminal kinase with opposing effects on cell survival.

Weyergang A, Kaalhus O, Berg K. Weyergang A, et al. Among authors: berg k. Mol Cancer Ther. 2008 Jun;7(6):1740-50. doi: 10.1158/1535-7163.MCT-08-0020. Mol Cancer Ther. 2008. PMID: 18566245

6

Photodynamic therapy targets the mTOR signaling network in vitro and in vivo.

Weyergang A, Berg K, Kaalhus O, Peng Q, Selbo PK. Weyergang A, et al. Among authors: berg k. Mol Pharm. 2009 Jan-Feb;6(1):255-64. doi: 10.1021/mp800156e. Mol Pharm. 2009. PMID: 19125612

7

Y1068 phosphorylation is the most sensitive target of disulfonated tetraphenylporphyrin-based photodynamic therapy on epidermal growth factor receptor.

Weyergang A, Selbo PK, Berg K. Weyergang A, et al. Among authors: berg k. Biochem Pharmacol. 2007 Jul 15;74(2):226-35. doi: 10.1016/j.bcp.2007.04.018. Epub 2007 Apr 27. Biochem Pharmacol. 2007. PMID: 17531956

8

Resistance mechanisms in photodynamic therapy.

Berg K. Berg K. Photochem Photobiol Sci. 2015 Aug;14(8):1376-7. doi: 10.1039/c5pp90026c. Epub 2015 Jul 27. Photochem Photobiol Sci. 2015. PMID: 26212047 No abstract available.

9

Photodynamic therapy mediated immune therapy of brain tumors.

Hirschberg H, Berg K, Peng Q. Hirschberg H, et al. Among authors: berg k. Neuroimmunol Neuroinflamm. 2018;5:27. doi: 10.20517/2347-8659.2018.31. Epub 2018 Jul 10. Neuroimmunol Neuroinflamm. 2018. PMID: 30221185 Free PMC article.

10

Photodynamic targeting of EGFR does not predict the treatment outcome in combination with the EGFR tyrosine kinase inhibitor Tyrphostin AG1478.

Weyergang A, Kaalhus O, Berg K. Weyergang A, et al. Among authors: berg k. Photochem Photobiol Sci. 2008 Sep;7(9):1032-40. doi: 10.1039/b806209a. Epub 2008 Jul 1. Photochem Photobiol Sci. 2008. PMID: 18754049

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,158 results

Search Page